Sort
10,766 grants matching “checkpoint inhibitor”
Drugging EBNA1 to Treat EBV-Associated Cancers
$128,992Troy E Messick · Wistar Institute · R01 · FY2024 · CA
Measuring and manipulating metabolic fluxes in the tumor microenvironment
$128,990Caroline Bartman · Princeton University · K99 · FY2022 · CA
Immune Monitoring and Flow Cytometry (IMFC)
$128,917Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2024 · CA
Immune Monitoring and Flow Cytometry (IMFC)
$128,915Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2023 · CA
Immune Monitoring and Flow Cytometry (IMFC)
$128,915Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2022 · CA
Immune Monitoring and Flow Cytometry (IMFC)
$128,915Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2020 · CA
Immune Monitoring and Flow Cytometry (IMFC)
$128,915Jacqueline Yvonne Channon Smith · Dartmouth College · P30 · FY2021 · CA
Targeting mitochondrial vulnerabilities to drive intrinsic melanoma immunogenicity
$128,798Jiaxin Liang · Dana-Farber Cancer Inst · K99 · FY2024 · CA
Targeting mitochondrial vulnerabilities to drive intrinsic melanoma immunogenicity
$128,798Jiaxin Liang · Dana-Farber Cancer Inst · K99 · FY2025 · CA
Core D: Translational Imaging Core
$128,635Ivan Pedrosa · Ut Southwestern Medical Center · P50 · FY2024 · CA
The integrated stress response and the microenvironment in melanoma progression
$128,632Constantinos Koumenis · University Of Pennsylvania · R01 · FY2025 · CA
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-Positive and HPV-Negative Penile Cancer
$128,511Magaly Martinez-Ferrer · University Of Puerto Rico Med Sciences · U54 · FY2020 · CA
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
$128,305Bolni Marius Nagalo · Mayo Clinic Arizona · K01 · FY2020 · CA
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
$128,305Bolni Marius Nagalo · Univ Of Arkansas For Med Scis · K01 · FY2021 · CA
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
$128,305Bolni Marius Nagalo · Mayo Clinic Arizona · K01 · FY2019 · CA
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
$128,305Bolni Marius Nagalo · Univ Of Arkansas For Med Scis · K01 · FY2022 · CA
Development of anti-PD-1-targeted chimeric antigen receptors and genetic circuits to deplete viral reservoirs in the nonhuman primate model of lentiviral infection
$128,250Karsten Eichholz · Fred Hutchinson Cancer Center · K01 · FY2025 · AI
Development of anti-PD-1-targeted chimeric antigen receptors and genetic circuits to deplete viral reservoirs in the nonhuman primate model of lentiviral infection
$128,250Karsten Eichholz · Fred Hutchinson Cancer Center · K01 · FY2024 · AI
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
$128,039Rafi Ahmed · Emory University · P50 · FY2024 · CA
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC
$128,039Xingming Deng · Emory University · P50 · FY2024 · CA
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$127,845Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
High-throughput screening for inhibitors of metabolic checkpoints on the G2/mitosis transition
$127,680Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Human leukocyte antigen and immune response in non-small cell lung cancer: A multi-omics approach
$127,629Xinan Wang · Harvard University D/B/A Harvard School Of Public Health · K99 · FY2025 · CA
Functional study of C53 protein as a novel regulator of checkpoint kinases
$127,409Honglin Li · Lurie Children'S Hospital Of Chicago · R01 · FY2009 · GM
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATION
$127,305Vanderbilt University · R01 · FY2002 · HD